Status:
ACTIVE_NOT_RECRUITING
PARADISE: Predicting AF After Cardiac Surgery
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
St. Bartholomew's Hospital
University College, London
Conditions:
Atrial Fibrillation New Onset
Eligibility:
All Genders
18+ years
Brief Summary
The PARADISE study aims to develop and validate prediction tools to identify patients at risk of Atrial Fibrillation (AF) after cardiac surgery.
Detailed Description
Atrial Fibrillation (AF) is a common abnormal heart rhythm. AF causes the heart to beat irregularly and sometimes very rapidly. About 30-50% of patients develop AF after heart surgery. These patients ...
Eligibility Criteria
Inclusion
- Patients 18 years or over
- Admitted to hospital for any cardiac surgery
Exclusion
- Patients who have requested that their data not be used for research (e.g. NHS Opt-out)
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
13684 Patients enrolled
Trial Details
Trial ID
NCT05255224
Start Date
October 1 2021
End Date
May 31 2025
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford
Oxford, Oxfordshire, United Kingdom, OX3 9DU